Press Room

2018 ECA Conference: Spray Drying

Start
Tuesday, April 10, 2018 - 00:00
End
Thursday, April 12, 2018 - 00:00
Location: Lisbon, Portugal
Spray Drying Contract Manufacturing large capacity | Hovione

HOVIONE PRESENTATIONS

10th of April
Marriott Hotel, Lisbon - Portugal

Applications of Spray Drying for Inhalation Products: case-studies
Eunice Costa

Scale-Up of a Spray Drying Process
João Vicente

ASDs by Spray Drying Supporting the development of oral dosage forms Supporting the development of oral dosage forms
João Henriques

 

In this three days conference dedicated to Spray Drying solutions, on the last day attendees have the opportunity to take advantage of an exclusive hands-on training. For that purpose several spray dryers are available at Hovione.

Hovione hosts a hands-on spray drying session in its site in Loures (Workshop is fully booked).

Our experts provide an intensive experience and directly applicable know-how.

For more details about our tecnhologies contact us.

 

More Details on ECA website: Spray Drying With Guided Tour at the Hovione Site

 

Also in the Press Room

See All

Continuous Tableting (CT) is defined as continuous manufacturing of oral dose drugs, specifically tablets. As per ICH's Q13 definition1, a continuous manufacturing process in the pharmaceutical industry comprises at least two unit operations integrated from a mechanical and software perspective. There is a wide combination of possible CT process configurations that are dependent on the needs of the intended product formulation and each of the individual unit operations that constitute the process train can be continuous, semi-continuous, or batch processes. The typical manufacturing processes for tablet formulation are direct compression (DC), dry granulation (DG) and wet granulation (WG)2 - details on these manufacturing processes are beyond the scope of this article, so the interested reader is directed to relevant literature. The actual implementation of CT technology in a facility can broadly vary depending on the level of desired integration and automation. Process trains can be designed to be flexible and converted between multiple configurations (e.g. continuous DC, DG and WG), controlled by the end user from one single software and within a single clean room. The other possibility would be for subsections of the CT process to be divided into multiple clean rooms where inprocess materials are transferred between suites via a bin-to-bin approach (e.g. a granulation suite to prepare granules from raw materials followed by continuous DC (CDC) to blend the granules and produce tablets). The level of automation and instrumentation designed into the CT process (typically involving Process Analytical Technologies, PAT) can open the possibility to implement sophisticated control strategies. Key components of a control strategy that need to be considered for CT are material tracking and genealogy, knowledge of the residence time distribution (RTD), and in-process controls (spectroscopic and/or soft sensors based on process parameters). Holistically, these control strategy elements enable the implementation of a material diversion strategy to automatically divert out of specification material from the process. In their most advanced form, control strategies may also enable real time release testing (RTRt) of the final tablet drug product and reduce the off-line analytical burden and the number of operators needed to manage the process.   Read the full article at gmp-journal.com  

Article

Continuous Tableting and the Road to Global Adoption

Mar 04, 2024